Overview
- 37 inspections across 35 sites are on record.
- 22 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-20.
At a glance
Inspections
37
Sites
35
Observations
22
Career since
Mar 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nice-Pak Products, Inc. | 20 Apr 2026 | Human Drugs | On file |
| RAYZEBIO INC | 24 Feb 2026 | Human Drugs | On file |
| Sentry Biopharma Services, Inc. | 17 Dec 2025 | Human Drugs | |
| Empower Clinic Services LLC | 14 Nov 2025 | Human Drugs | On file |
| JHK, Inc. | 11 Sep 2025 | Human Drugs | On file |
Sites inspected
Nice-Pak Products, Inc.Mooresville, United States1 insp.
RAYZEBIO INCIndianapolis, United States1 insp.
Sentry Biopharma Services, Inc.Indianapolis, United States1 insp.
Empower Clinic Services LLCHouston, United States1 insp.
JHK, Inc.Osceola, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Eboni S Funderburk6 shared
Sandra A Boyd4 shared
Claudia M Perez-Kasmarski3 shared
Scott D Mcgrew2 shared
Supreet K Sran1 shared
Anna M Spiros1 shared
Joohi Castelvetere1 shared
Andrew J Barrowcliff1 shared
Mia J Chang1 shared
Matthew M Schuckmann1 shared
Full investigator report
Get the verbatim findings behind Muna Algharibeh's 22 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site